test

Nnamdi Etoh

@Rock Springs Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$3.074BTotal holdings109
Assets growth rate-7.48%Assets growth rate (2-Q avg)-11.56%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Rock Springs Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 109 positions.

Assets under management

The assets under management (AUM) of Rock Springs Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.074B in assets, with a quarterly growth rate of -7.48% and a 2-quarter average growth rate of -11.56%. The portfolio is managed by Nnamdi Etoh, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BCRXBiocryst Pharmaceuticals Inc
Recent Activity
Increased 0.09%
0.9%
$27.53M
3.622M shares@ $7.61 avg price
LEGNLegend Biotech Corp
Recent Activity
Increased 0.63%
0.81%
$24.8M
508,932 shares@ $48.73 avg price
INZYInozyme Pharma Inc
Recent Activity
Increased 2.83%
0.65%
$19.889M
3.803M shares@ $5.23 avg price
VERAVera Therapeutics Inc
Recent Activity
Increased 0.61%
0.56%
$16.95M
383,492 shares@ $44.2 avg price
APLTApplied Therapeutics Inc
Recent Activity
Increased 12.32%
0.49%
$14.845M
1.746M shares@ $8.51 avg price
FOLDAmicus Therapeutics Inc
Recent Activity
Increased 2.61%
0.44%
$13.353M
1.25M shares@ $10.68 avg price
CGEMCullinan Therapeutics Inc
Recent Activity
Increased 11.94%
0.41%
$12.336M
736,914 shares@ $16.74 avg price
NMRANeumora Therapeutics Inc.
Recent Activity
Increased 8.96%
0.36%
$10.939M
828,101 shares@ $13.21 avg price
CMPXCompass Therapeutics Inc
Recent Activity
Increased 2.1%
0.34%
$10.358M
5.629M shares@ $1.85 avg price
JSPRJasper Therapeutics Inc
Recent Activity
Increased 13.55%
0.29%
$8.635M
459,088 shares@ $18.81 avg price